Why the study?
T2DM complicated with NAFLD has complex pathogenic processes, and identifying the main risk factors driving progression to HCC is needed to guide diagnosis, treatment, and early prevention.
This review highlights the need to identify risk factors for the progression of T2DM with NAFLD to HCC and explores the potential of traditional Chinese medicine in its management.
Type 2 diabetes mellitus (T2DM) with nonalcoholic fatty liver disease (NAFLD) is a pathological metabolic disease characterized by high ketone lipid based on abnormal lipid metabolism. Compared with patients with single T2DM or NAFLD, T2DM complicated with NAFLD has more complicated pathogenic factors and pathological processes. Hepatocellular carcinoma (HCC), the leading malignancy arising from cirrhosis, is the second most lethal cancer globally. The purpose of this study was to clarify the main risk factors of T2DM with NAFLD and HCC. There are many challenges in the diagnosis and treatment of T2DM patients with NAFLD and HCC. The current gold standard is to adjust treatment strategy, optimize metabolic control, and improve liver phenotype. It is necessary to identify further the risk factors driving the progression of T2DM with NAFLD and HCC and evaluate new therapeutic targets, in addition to exploring the syndromic forms of T2DM combined with NAFLD and providing a theoretical basis for early prevention, diagnosis, and treatment of the disease using traditional Chinese medicine (TCM).
No takes yet. Share an insight, caveat, or question.
Qi et al. (2021) conducted a review in Type 2 diabetes mellitus with nonalcoholic fatty liver disease and hepatocellular carcinoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: